MONOPTY 121620Recalls & reported problems
Bard Peripheral Vascular, Inc. · MONOPTY® Disposable Core Biopsy Instrument, 22mm penetration depth, 16g x 20cm · Class 2
All models of MONOPTY (13)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00801741084621), received between Jun 28, 2018 and Oct 28, 2025 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Self-Activation or Keying” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Self-Activation or Keying3
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Device Dislodged or Dislocated1
- Failure to Prime1
Patient problems
- No Patient Involvement2
- No Clinical Signs, Symptoms or Conditions1
- Rupture1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 28, 2025Break; Self-Activation or Keying; Device Dislodged or Dislocated; Break; Self-Activation or Keying; Device Dislodged or Dislocated
ON (B)(6) 2025, A PATIENT UNDERWENT A BIOPSY PROCEDURE USING THE MONOPTY DEVICE, UPON OPENING THE NEEDLE BOX, THE INSTRUMENT BODY WAS BROKEN. ANOTHER CANNULA NEEDLE WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO PATIENT CONTACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23399703 ↗InjuryFeb 24, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING AN ECHO-GUIDED LIVER BIOPSY PROCEDURE, THE INNER CYLINDER HAD ALLEGEDLY TORE THE PATIENT'S GALLBLADDER WALL. IT WAS FURTHER REPORTED THAT THE PATIENT HAD ALLEGEDLY DEVELOPED CHOLECYSTITIS AFTER THE PROCEDURE. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.
Patient problems: Rupture
MAUDE report 21444596 ↗MalfunctionOct 16, 2019Self-Activation or Keying; Self-Activation or Keying
THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL 121620 BIOPSY INSTRUMENT ALLEGEDLY SELF-ACTIVATED. THERE WAS NO REPORTED PATIENT CONTACT. THIS INFORMATION WAS RECEIVED FROM ONE SOURCE. PATIENT AGE, WEIGHT, AND GENDER WERE NOT PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 9200111 ↗MalfunctionJun 28, 2018Failure to Prime; Self-Activation or Keying; Failure to Prime; Self-Activation or Keying
IT WAS REPORTED THAT PRIOR TO A BIOPSY, THE DEVICE ALLEGEDLY WAS DIFFICULT TO PRIME. THERE WAS NO PATIENT CONTACT.
Patient problems: No Patient Involvement
MAUDE report 7648499 ↗
Other INSTRUMENT, BIOPSY devices
- MAX-CORE MC1616Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall4,258 reports
- ENCOR® ECP017GSenorx, Inc. · INSTRUMENT, BIOPSY1 recall4,186 reports
- MAX-CORE MC1820Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall2,404 reports
- MAX-CORE MC1816Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall1 death848 reports
- MAX-CORE MC1410Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall399 reports
- MAX-CORE MC1610Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall394 reports
- ENCOR® ECP0110GVSenorx, Inc. · INSTRUMENT, BIOPSY392 reports
- ENCOR® ECP0110GSenorx, Inc. · INSTRUMENT, BIOPSY390 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page